fbpx

JCAHO Accredited

Call Us 800-444-1838

World No Tobacco Day is May 31

It might go without saying that smoking cigarettes is bad for the lungs, though the World Health Organization (WHO), which sponsors World No Tobacco Day on May 31 along with partners, reports that in some countries there is a lack of knowledge about the severe damage cigarettes have on lung health. Worldwide, tobacco use kills […]

National Alcohol and Other Drug-Related Birth Defects Awareness Week

May 12 to 18, 2019 Mother’s Day marks the beginning of National Alcohol and Other Drug-Related Birth Defects Awareness Week, sponsored by the National Council on Alcoholism and Drug Dependence (NCADD). This nationwide campaign hopes to raise awareness and educate people, especially women, of the dangers of using drugs or alcohol during pregnancy. Drug and […]

Borderline Personality Disorder Awareness Month in May

Borderline Personality Disorder (BPD) is a mental health condition that makes it difficult for a person to regulate their emotions. The prevalence of the condition in the United States is difficult to measure because of the high incidence of misdiagnosis, but the National Alliance on Mental Illness (NAMI) estimates nearly 6 percent of the population […]

What Happens to Your Body When You Stop Vaping?

Regardless of the narrative that marketing companies and “big tobacco” try to sell, vaping – the use of electronic cigarettes (e-cigs) – is not necessarily a safe alternative to smoking cigarettes. E-cig battery-powered heating elements turn addictive liquid nicotine, which can come in various flavors and added chemicals, into vapor that users inhale. Unfortunately, business […]

7 Reasons Millennials Are Drinking Less Alcohol Than Older Generations

It’s true, Millennials – people around the ages of 22 to 38 years old – are changing up the alcohol consumption game. This news, while positive and a move in the right direction, still comes with a dose of reality. Alcohol remains the third leading cause of preventable death in the United States and is […]

Spravato (Esketamine) for Treatment Resistant Depression – An FDA Approved “Breakthrough Therapy”

In March 2019, the U.S. Food and Drug Administration (FDA) announced the approval of Spravato (Esketamine) for use in patients diagnosed with treatment-resistant depression. Spravato is a nasal spray that can only be administered by an approved health care provider, in the physician’s office or clinic, because the main ingredient is a chemical relative of […]